Admission required for serial exams and source control
Treatment
Antibiotics
Empiric broad spectrum regimen
Core coverage goals
Streptococci and MSSA
MRSA
Gram negative organisms
Anaerobes
Standard severe NSTI regimen
Piperacillin tazobactam IV 4.5 g every 6 hours
Renal adjustment for reduced eGFR
Extended infusion per local protocol if available
Vancomycin IV 15 to 20 mg/kg loading
Target AUC based dosing per local protocol
Trough based approach only if AUC unavailable
Clindamycin IV 900 mg every 8 hours
Toxin suppression for streptococci and staphylococci
Continue even if cultures show streptococci
Alternative beta lactam strategy
Meropenem IV 1 g every 8 hours
Use for ESBL risk or severe polymicrobial infection
Renal adjustment required
Cefepime IV 2 g every 8 hours
Add metronidazole IV 500 mg every 8 hours for anaerobes
Avoid monotherapy for anaerobes
Specific exposure guided additions
Seawater exposure with severe SSTI
Doxycycline IV 100 mg every 12 hours
Add to broad regimen for Vibrio coverage
Avoid in pregnancy if alternatives available
Freshwater exposure with severe SSTI
Ciprofloxacin IV 400 mg every 12 hours
Consider for Aeromonas coverage
QT prolongation risk review
Evidence level framing
Class I recommendation for early broad spectrum antibiotics in sepsis with suspected source
ACEP Level B recommendation for early antibiotics in septic shock pathways
Surgery and source control
Operative management
Surgical exploration
Early exploration for high suspicion despite equivocal imaging
Bedside incision and fascial inspection only if immediate OR unavailable
Debridement principles
Wide excision of necrotic fascia and nonviable tissue
Tissue viability reassessment at each surgery
Repeat debridement within 12 to 24 hours typical
Intraoperative cues
Gray necrotic fascia
Lack of bleeding
Thin dishwater fluid
Easy finger dissection along fascial planes
Evidence level framing
Class I recommendation for urgent surgical debridement as definitive therapy
Hemodynamic resuscitation and organ support
Sepsis management bundle
Fluids
Balanced crystalloid 30 ml/kg for hypotension or lactate elevation
Smaller boluses with frequent reassessment if heart failure risk
Vasopressors
Norepinephrine infusion initiation if persistent hypotension after fluids
Titrate every 2 to 5 minutes to MAP target
Peripheral initiation via large bore IV acceptable with close monitoring
Vasopressin infusion addition if high norepinephrine requirement
Fixed dose per local protocol
Norepinephrine sparing strategy
Epinephrine infusion consideration if refractory shock
Add on agent in septic shock
Lactate interpretation caution
Steroids
Hydrocortisone IV 50 mg every 6 hours for refractory septic shock
Consider if vasopressor dependent despite adequate fluids
Class IIa recommendation in refractory shock contexts
Ventilation
Lung protective ventilation if intubated
Target oxygenation avoiding hyperoxia
Monitoring
Repeat lactate within 2 to 4 hours if elevated
Strict intake and output
Glucose control with insulin protocol as needed
Adjunctive therapies
Toxin mediated syndrome management
Clindamycin continuation
Continue with confirmed group A streptococcus
Continue with suspected streptococcal toxic shock syndrome
IVIG considerations
Consider in streptococcal toxic shock syndrome with shock despite source control and antibiotics
Dose strategy per local protocol and specialist guidance
Evidence uncertainty acknowledged
Hyperbaric oxygen
Use limitations
Not a substitute for surgery
Consider only after debridement and stabilization
Transfer decisions should not delay initial surgery
Anticoagulation and DVT prophylaxis
Pharmacologic prophylaxis when bleeding risk acceptable
Mechanical prophylaxis if high bleeding risk
Special Populations
Pregnancy
Pregnancy considerations
Maternal priorities
Maternal stabilization and source control as first priority
Early obstetric consultation for viable gestations
Antibiotic selection
Beta lactams generally compatible
Vancomycin use with therapeutic drug monitoring
Clindamycin generally compatible
Avoid doxycycline when alternatives available
Imaging considerations
Ultrasound adjunct when feasible
CT with contrast acceptable when needed for maternal life saving decisions
Fetal shielding per radiology protocol when possible
Geriatric
Older adult considerations
Atypical presentation risk
Blunted fever response
Baseline frailty masking severity
Medication considerations
Renal dosing adjustment for beta lactams and vancomycin
Higher delirium risk with sedatives and opioids
Prognostic considerations
Higher mortality with delayed debridement
Lower physiologic reserve in shock
Pediatrics
Pediatric considerations
Presentation
Severe pain and irritability
Refusal to bear weight with limb involvement
Varicella associated invasive group A streptococcus risk
Antibiotic dosing
Weight based vancomycin dosing per local pediatric protocol
Clindamycin weight based dosing per local pediatric protocol
Broad beta lactam weight based dosing per local protocol
Disposition
Early pediatric surgery consultation
PICU for shock or organ dysfunction
Background
Epidemiology
Disease burden and classification
Incidence overview
Rare but high mortality infection
Higher incidence in diabetes and immunocompromise
Microbiologic types
Type I polymicrobial infection
Type II monomicrobial group A streptococcus with or without staphylococcus
Type III gram negative monomicrobial including Vibrio and Aeromonas
Type IV fungal necrotizing infection in immunocompromised hosts
Mortality drivers
Delay to surgery increases mortality risk
Shock at presentation increases mortality risk
Comorbid organ dysfunction increases mortality risk
Pathophysiology
Mechanisms of tissue destruction
Fascial plane spread
Thrombosis of small vessels
Ischemia and tissue necrosis
Rapid extension beyond skin findings
Toxin mediated injury
Superantigen effects in streptococcal disease
Capillary leak and shock physiology
Gas formation pathways
Anaerobic fermentation in polymicrobial infection
Clostridial toxin mediated myonecrosis
Therapeutic Considerations
Treatment principles
Time dependency
Early surgery as definitive therapy
Antibiotics as adjunct to source control
Antibiotic rationale
Broad coverage for polymicrobial disease at presentation
Clindamycin for toxin suppression and inoculum effect mitigation
Resuscitation rationale
Shock driven organ failure risk
Early vasopressors to maintain perfusion
Evidence level framing
Class I recommendation for urgent debridement
Class I recommendation for early broad spectrum antibiotics in septic shock
ACEP Level C recommendation for avoiding imaging delays when high suspicion
Patient Discharge Instructions
Copy discharge instructions
Post hospitalization and wound care guidance
Wound care plan
Dressing changes per surgical team instructions
Keep wound clean and dry unless instructed otherwise
Hand hygiene before and after wound care
Medications
Take antibiotics exactly as prescribed
Pain medicine safety and constipation prevention plan
Follow up plan
Surgical follow up appointment date and time
Infectious diseases follow up if arranged
Wound care clinic follow up if arranged
Return immediately to emergency department
Fever
Worsening pain
New redness or swelling spreading rapidly
New blisters or skin color change
Foul drainage
Confusion
Fainting
Trouble breathing
Decreased urine output
References
Guidelines and high yield sources
Core guidance sources
IDSA clinical practice guideline for skin and soft tissue infections with necrotizing infection recommendations
Early surgical exploration emphasized
Broad empiric antibiotics with MRSA and anaerobe coverage emphasized
Surviving Sepsis Campaign guidelines for sepsis and septic shock
Early fluids for hypoperfusion
Norepinephrine as first line vasopressor
ACEP sepsis policy statements and clinical pathways
Early antibiotics and resuscitation pathway alignment
Microbiology and toxin suppression references
Evidence for clindamycin toxin suppression in invasive group A streptococcus
Use as adjunct regardless of penicillin susceptibility
Benefit signal strongest in toxic shock presentations
Diagnostic adjunct references
Literature on LRINEC score performance limitations
Reduced sensitivity in early presentations
Not suitable as exclusion tool
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.